About SOL Bio
SOL Bio is a company based in Seoul (South Korea) founded in 2019 by Se Hwan Paek. SOL Bio offers products and services including NeutraRelease, ExoMAIN, ExoBead, and ExoDAb. SOL Bio operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter Seoul, South Korea
- Founders Se Hwan Paek
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 솔바이오 주식회사
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SOL Bio
SOL Bio offers a comprehensive portfolio of products and services, including NeutraRelease, ExoMAIN, ExoBead, and ExoDAb.
Protocol for efficient exosome isolation in liquid biopsy tests
Tool for molecular diagnosis using exosome subpopulations
Beads for handling and isolating exosomes
Antibodies for exosome detection and analysis
Funding Insights of SOL Bio
Detailed funding history for SOL Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SOL Bio
Investment portfolio details for SOL Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SOL Bio
Detailed financials for SOL Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sol Bio Comparisons
Peer comparison for SOL Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SOL Bio
SOL Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
Detailed competitors of SOL Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sol Bio
Complete news archive for SOL Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SOL Bio
SOL Bio was founded in 2019.
SOL Bio is headquartered in Seoul, South Korea.
Se Hwan Paek is the current CEO of SOL Bio. They have also founded this company.
Developer of platform for screening of multi-cancer diagnostics. The company has in vitro diagnostic products which include an exosome isolation kit, prostate cancer screening, expand to 5 cancer types, a biosensor model, and others. It is based on technologies that include 2D chromatography-based biosensors, hybrid biochips, liquid biopsy using exosomes, animal cell-based biochips, and immunosensor.
SOL Bio's top competitors include Guardant Health, GRAIL and Strand Life Sciences.
SOL Bio offers NeutraRelease, ExoMAIN, ExoBead, and ExoDAb.